Contact Us
Contact Us
Home Finance Protagonist Therapeutics authorizes $300 million buyback plan
Finance

Protagonist Therapeutics authorizes $300 million buyback plan

September 8, 20261 Mins read0
Share
Protagonist Therapeutics authorizes 0 million buyback plan
Share


Protagonist Therapeutics authorizes $300 million buyback plan

Source link

Share
Harbour Energy at Barclays conference: cash flow surge drives strategy Previous post Harbour Energy at Barclays conference: cash flow surge drives strategy

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
BMO initiates On Holding stock coverage at Market Perform, target
Finance

BMO initiates On Holding stock coverage at Market Perform, $28 target

BySeptember 8, 2026
FDA names permanent leaders for drug, biologics and tobacco centers
Finance

FDA names permanent leaders for drug, biologics and tobacco centers

BySeptember 8, 2026
Ares Capital prices 0 million notes offering at 6.25%
Finance

Ares Capital prices $750 million notes offering at 6.25%

BySeptember 8, 2026
Trump directs GSA to take steps to remove Canadian goods from agency lists
Finance

Trump directs GSA to take steps to remove Canadian goods from agency lists

BySeptember 8, 2026
© Copyright 2024 Jellywp. All rights reserved powered by Jellywp.com